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SYNOPSIS/PRECIS 
 
OCT angiography detected decreased capillary density in retinal plexuses of USH2A 
and MYO7A patients. Choriocapillaris defects were detected in MYO7A but not USH2A. 
Decreased vessel density was associated with abnormal macular sensitivity and 
ellipsoid zone loss.  
ABSTRACT 
 
Aims: Using optical coherence tomography angiography (OCTA) to characterize 
microvascular changes in the retinal plexuses and choriocapillaris (CC) of MYO7A and 
USH2A patients, and correlate with genotype, retinal structure and function. 
Methods: Twenty-seven molecularly-confirmed USH2A (n=21) and MYO7A (n=6) 
patients underwent macular 6x6mm OCTA using the AngioVue. Heidelberg spectral-
domain OCT scans and MAIA microperimetry were also performed, the preserved 
ellipsoid zone (EZ) band width and mean macular sensitivity were recorded. OCTA of 
the inner retina, superficial capillary plexus (SCP), deep capillary plexus (DCP), and CC 
were analysed. Vessel density (VD) was calculated from the en face OCT angiograms 
of retinal circulation. 
Results: Forty eight eyes with either USH2A (n=37, mean age: 34.4±12.2 years) or 
MYO7A (n=11, mean age: 37.1±12.4 years), and 35 eyes from 18 Age-matched healthy 
participants were included. VD was significantly decreased in the retinal circulation of 
USH2A and MYO7A patients compared to controls (p<0.001). Changes were observed 
in both the SCP and DCP, but no differences in retinal perfusion were detected between 
USH2A and MYO7A groups. No vascular defects were detected in CC of the USH2A 
group, but peripheral defects were detected in older MYO7A patients from the fourth 
decade of life. Vessel density in the DCP showed strong association with macular 
sensitivity and EZ width (Spearman’s rho=0.64 and 0.59, respectively, p<0.001). 
Conclusion: OCTA was able to detect similar retinal microvascular changes in USH2A 
and MYO7A patients. The CC was generally affected in MYO7A patients. OCT 
angiography may further enhance our understanding of inherited eye diseases, and 
their phenotype-genotype associations.  
INTRODUCTION 
Usher syndrome (USH) is an autosomal recessive disorder characterized by congenital 
sensorineural hearing loss and retinitis pigmentosa, with or without vestibular 
dysfunction.[1] USH has an estimated prevalence of ~1:12,000-28,000, and is thought to 
be responsible for more than 50% of patients with combined deaf-blindness.[2-4] Retinitis 
pigmentosa (RP) is a progressive pigmentary degeneration of rod and cone 
photoreceptors leading to sight loss.[5] Patients commonly present with nyctalopia, then 
constriction of peripheral vision, and eventually loss of central vision in the late stages of 
the disease. Fundus examination classically reveals the triad of pigmentary changes 
(bone spicules) at the midperiphery, waxy pale optic disc, and generalized arteriolar 
attenuation. 
Usher syndrome has been classically divided into three clinical subtypes, based on age 
of onset, severity, and vestibular features.[6 7] Usher type 1 (USH1) is the most severe 
form of the disease with profound hearing and vestibular function loss, with RP presenting 
during childhood. Usher type 2 (USH2) is the most common type, which is characterized 
by partial hearing loss and presentation of RP in adolescence/early adulthood, with intact 
vestibular function. Hearing loss tends to be non-progressive in patients with USH1 and 
USH2.[6] In contrast, type 3 Usher syndrome (USH3) exhibits slowly progressive hearing 
loss and variable degree of vestibular dysfunction with RP.[7] 
To date, USH has been associated with at least 19 loci, with 16 causative genes 
identified.[8] Mutations in MYO7A and USH2A genes are the most common causes of 
USH, responsible for more than 50% of USH1 and 70% of USH2, respectively.[9-13] 
MYO7A and USH2A genes encode the proteins myosin VIIa and usherin, respectively. 
Both proteins are essential for the structural and functional integrity of the cochlear hair 
cells of the inner ear and photoreceptors in the retina.[14 15] Myosin VIIa is further 
expressed in the retinal pigment epithelium (RPE),[16] as well as in the vestibular utricule 
and macula.[17] Mutations in USH2A have also been associated with non-syndromic 
autosomal recessive RP,[18] whereas MYO7A have been associated with non-syndromic 
hearing loss.[19] 
Several therapeutic approaches have been introduced for the treatment of USH,[20] 
including gene augmentation therapy,[21] nonsense suppression therapy,[22] as well as 
ciliary neurotrophic factor (CNTF)-releasing cell therapy.[23] However, reliable and 
objective measurements are needed to assess disease progression and establish 
outcomes parameters of future clinical interventions. Optical coherence tomography 
angiography (OCTA)[24] has recently been introduced as a non-invasive functional 
extension of OCT technology that has the ability to provide depth-resolved visualization 
and quantification of retinal and choroidal microvasculature.[25 26] OCTA was used to 
investigate individual retinal plexuses, as well as choriocapillaris (CC) in patients with 
RP.[27-30] A decreased vascular density was generally observed in the superficial 
capillary plexus (SCP), deep capillary plexus (DCP), and CC of RP patients. Retinal 
perfusion has been reported to be correlated with visual function.[31 32] However, these 
studies included either a molecularly unconfirmed or genotypically- heterogeneous cohort 
of patients. Given the known variation between degeneration rate and genotype, this 
heterogeneity inhibits the evaluation of vascular change as a metric of disease. 
In this study, we aim to characterize vascular changes in the superficial and deep retinal 
capillary plexuses, as well as choroidal circulation in a cohort of patients with mutations 
in MYO7A and USH2A genes. We will also investigate the relationship between vascular, 
structural, and functional changes in these patients. 
 
MATERIALS AND METHODS 
Study Population 
Twenty-seven patients with confirmed biallelic variants in USH2A (n=21) and MYO7A 
(n=6) were recruited from Moorfields Eye Hospital between May 2017 and December 
2018. Eighteen age-matched healthy participants were also included in this prospective 
observational study. The study was approved by the national research ethics committee 
and all participants gave informed consent to participate. All study procedures adhered 
to the tenets of the Declaration of Helsinki. Exclusion criteria for patients included the 
presence of any retinal disease other than RP, or the inability to obtain reliable OCTA 
scans. Healthy control participants were selected based on (i) lack of any anatomically-
modifying retinal disease such as glaucoma, diabetic retinopathy, and/or retinal 
detachment, (ii) ability to obtain OCTA scans, (iii) LogMAR best corrected visual acuity 
(BCVA) ≤0.3, and (iv) no history of major eye trauma or surgery. Detailed medical history 
was taken from patients, and comprehensive ophthalmological examination was 
performed including LogMAR BCVA and slit lamp examination. Both eyes from each 
participant were included.  
OCT and OCTA Acquisition 
High resolution OCT line scans were acquired from patients using Spectralis HRA+ OCT 
machine (Heidelberg Engineering, Inc., Heidelberg, Germany). The scanning protocol 
acquired 20°x20° (~6.3 mm) volumetric scans (193 B-scans, each consisting of 1024 A-
scans). Image volumes were inspected to ensure the horizontal foveal scan was acquired. 
All participants underwent OCTA scanning using a commercially available spectral-
domain OCT system (Avanti RTVue XR machine, OptoVue, Inc., Fremont, CA, USA). 
This system has an acquisition speed of 70k A-scans/second, macular 6x6 mm scans 
were acquired. Each data set was created by orthogonal registration and merging of 1 x-
fast and 1 y-fast scans. Blood flow was detected using a commercial version of split-
spectrum amplitude-decorrelation angiography (SSADA) algorithm.[24] Scans collected 
were either the traditional 304x304 scans or the high density (HD) 400x400 scans. 
 
 
Microperimetry 
Patients were tested for macular sensitivity using Macular Integrity Assessment (MAIA, 
CenterVue SpA, Padova, Italy). The default (Expert Exam) mesopic protocol was used. 
The stimulus was Goldmann size III, with presentation time of 200 ms. Sensitivity 
measures were obtained by 4-2 strategy at 37 points distributed in 3 concentric circles 
covering an area of 10 degrees in diameter (Figure 1). Mean macular sensitivity (MS) was 
calculated from the measured sensitivities at the 37 points using the on instrument 
software. 
All microperimetry results underwent a fixation-based quality-control check to ensure 
reliability. Examinations with high fixation loss rate (>30%) were excluded. Macular 
Integrity Index is a numerical value indicating the likelihood of a statistically significant 
alteration in macular sensitivity when compared with age-matched normal values.  Mean 
sensitivity and macular sensitivity values and maps were collected and qualitatively 
assessed for co-localization with OCT and OCTA values.  
Data Processing 
Spectralis structural OCT images were viewed and analysed using the Heidelberg Eye 
Explorer (HEYEX) software. The B-scan passing through the center of the fovea was 
selected, and an expert grader manually identified the extension of ellipsoid zone (EZ) 
band from the cross-sectional OCT image, and the width of the preserved EZ was 
measured.[33] 
OCT angiography scans were checked for image quality and segmentation using the 
ReVue software (OptoVue, Inc., Fremont, CA, USA). Low quality scans (Q less than 5/10, 
significant motion artifacts, defocused, or non-centered) were excluded from analysis. 
Due to the significant pathological changes in USH retinas, automated segmentation 
failed frequently and manual correction was needed. The retina was segmented at the 
inner limiting membrane (ILM), inner plexiform layer (IPL), and Bruch’s membrane (BM). 
As the segmentation of the outer boundary of outer plexiform layer (OPL) was technically 
difficult due to the extensive retinal degeneration and poor visualization, a line 25 μm 
above the segmented BM (BM-25 μm) was used as an outer boundary of the inner retinal 
slab. En face OCT angiograms were generated by maximum projection of flow signal at 
specific slabs (Figure 1). The inner retinal slab was defined between ILM and 25 μm 
above BM. The retinal circulation was then subdivided into superficial and deep capillary 
plexuses. The SCP lies between the ILM and 9 μm above the IPL (IPL-9 μm). The DCP 
was detected between IPL-9 um and BM-25 μm. Choriocapillaris (CC) slab was defined 
between BM-9 μm and BM+31 μm. 
En face angiograms were then exported using the “Export Angio” tool in ReVue software 
into PNG files for analysis using custom Matlab and ImageJ routines. Due to retinal 
degeneration, larger vessels from the superficial layers were partially displaced and 
appeared in the DCP slab, potentially interfering with accurate quantification of flow 
signal. Thus, areas occupied with large vessels were identified and excluded from the 
analysis of DCP angiograms. Vessel density (VD) was measured from threshold en face 
angiograms within a 6-mm diameter annular region outside the manually-centered 0.6 
mm-diameter foveal avascular zone (FAZ) (Figure 1). VD was defined as the percentage 
of the area occupied by pixels containing flow signal. FAZ was excluded from analysis to 
avoid the normal variability of FAZ area between subjects. 
Statistical Analysis 
All statistical analyses were performed on SPSS v. 25.0 (IBM Corporation, Armonk, NY, 
USA) and Microsoft Excel 2017 (Microsoft Office, Microsoft Corporation, Redmond, WA, 
USA). Vessel density, width of the preserved EZ, and mean macular sensitivity were 
presented as mean and standard deviation (SD) of the included participants in each 
group. Age-matching between groups was assessed using analysis of variance (ANOVA) 
test. Generalized estimating equations (GEE) was used to investigate the differences 
between groups. GEE tests account for the within-subject correlation between both eyes. 
P values were adjusted for multiple comparisons using Holm-Bonferroni correction. 
Spearman’s rank correlation coefficient (rho) was used to assess the correlation between 
VD, EZ, and MS. 
 
RESULTS 
Participant Characteristics, Clinical Data, and Genetic Findings 
Forty eight eyes from 27 patients (mean age ± SD, 35.0 ± 12.1 years) with bialleleic 
variants in either MYO7A or USH2A genes were included (see supplemental Table 1 for 
details of mutations). Thirty five eyes from 18 healthy participants (mean age ± SD, 34.0 
± 10.4 years) were included. The majority of patients had clinical manifestations of USH1 
or USH2, with the exception of 3 USH2A patients who had non-syndromic autosomal 
recessive RP (ARRP) with no associated hearing loss (see Table 1). Patients and control 
groups were age-matched (p = 0.25, ANOVA). No statistically significant difference in 
central vision was found between USH2A and MYO7A patients (mean LogMAR ± SD, 
0.31 ± 0.18 and 0.19 ± 0.23, respectively, p = 0.26). 
 
 
TABLE 1. Characteristics of enrolled participants  
 Control USH2A MYO7A 
No. of participants 18 21 6 
Gender    
     Male 11 11 2 
     Female 7 10 4 
Phenotype N/A   
     USH1 N/A N/A 6 
     USH2 N/A 18 N/A 
     ARRP N/A 3 N/A 
    
No. of eyes 35 37 11 
Age  34.0 ± 10.4 34.4 ± 12.2 37.1 ± 12.4 
     Range 23-61 years 19-56 years 18-52 years 
LogMAR  N/A 0.19 ± 0.23 0.31 ± 0.18 
Axial Length (mm) N/A 23.69 ± 1.40 23.53 ± 0.91 
    
Age, LogMAR and axial length are given as mean ± standard deviation. 
USH1 and USH2: Usher syndrome type 1 and 2, respectively, ARRP: 
autosomal recessive retinitis pigmentosa, LogMAR: logarithm of the 
minimum angle of resolution, N/A: not applicable 
 
OCT Angiography, Structural OCT, and Microperimetry 
Qualitative evaluation of OCT angiograms of retinal circulation revealed decreased 
capillary density in the inner retina, SCP, and DCP of USH patients, compared to controls 
(Figure 1). The decreased perfusion was more pronounced at the peripheral regions of 
the angiograms, with relatively preserved vascularity at central regions. Quantitatively, 
statistically significant reductions in vessel density were observed in patients compared 
to controls in all retinal plexuses (p < 0.001, GEE) (Table 2 and Figure 2). However, no 
significant differences were observed in retinal angiograms between MYO7A and USH2A 
groups (Table 2). In contrast, CC seemed to behave differently in USH2A and MYO7A 
patients. Patients with USH2A mutations had relatively intact CC layer throughout 
different age groups (19-55 years) (Figure 3, B1-3), except one USH2 patient (56 years 
old) who had marked retinal degeneration and RPE loss which associated with localized 
loss of CC. On the other hand, CC angiograms of MYO7A patients showed microvascular 
changes starting from third or fourth decade of life (Figure 3). Areas of lost CC was 
observed at the periphery of the 6 mm angiogram, exposing the deeper and less dense 
large choroidal vessel layers (Figure 3, white arrows in C2 and C3). A ring of increased 
flow signal was detected around the intact CC island, at the transitional area between 
preserved and lost CC (Figure 3, yellow arrow heads in C2 and C3). 
Cross-sectional structural OCT images of USH patients revealed photoreceptor loss, 
evident by the extensive degeneration of EZ and outer nuclear layer (ONL) at the 
periphery of the scanned retina (Figure 1). USH patients showed an average of 1442 ± 
1163 um of preserved EZ band at the horizontal B-scan at the center of the fovea. No 
significant difference was observed in the mean EZ between MYO7A and USH2A 
patients. 
The microperimetry detected decreased mesopic macular sensitivity (mean ± SD, 15.6 ± 
8.2 dB) in all patients, especially at the peripheral areas (Figure 1), with all patients 
identified as having abnormal Macular Integrity index, except for one patient who had 
“suspect” integrity. MYO7A patients had a slightly lower mean macular sensitivity than 
USH2A patients; however, the differences were found not to be statistically significant (p 
= 0.66, GEE). 
Correlation between Vascular, Structural, and Functional Parameters 
Areas of degenerated retina on structural OCT spatially co-localized with areas of 
hypoperfusion on OCTA and decreased sensitivity on the retinal sensitivity map (Figure 
1). Vessel density of retinal plexuses significantly correlated with mean sensitivity and 
the width of the preserved EZ (Figure 2). The deep plexus showed slightly stronger 
associations with OCT (Spearman’s rho = 0.59, p < 0.001) and microperimetry (rho = 
0.64, p < 0.001) than the superficial plexus. 
 
 
 
DISCUSSION 
Arteriolar attenuation is a classic sign in Usher-related retinitis pigmentosa. In our cohort 
of MYO7A and USH2A patients, OCTA was able to detect decreased perfusion in retinal 
plexuses, especially in the more peripheral areas, with a relatively preserved central 
macula. The deep plexus was found to be more affected than the superficial layer. 
Although the choriocapillaris in USH2A patients appeared to be relatively preserved until 
late stages of the disease, in MYO7A there was marked early loss of this layer compared 
TABLE 2. Vessel density, EZ width and retinal sensitivity measurements 
 
Control USH2A MYO7A 
Control vs. USH2A Control vs. MYO7A USH2A vs. MYO7A 
% change P value % change P value % change P value 
OCT 
Angiography 
Inner (%) 75.51 ± 3.09 51.51 ± 7.77 47.91 ± 5.99 -31.78% < 0.001 -36.54% < 0.001 -6.98% 0.58 
 SCP (%) 61.10 ± 4.74 48.37 ± 7.26 46.30 ± 4.51 -20.84% < 0.001 -24.22% < 0.001 -4.27% 0.43 
 DVC (%) 27.67 ± 4.06 13.79 ± 4.97 12.11 ± 4.88 -50.16% < 0.001 -56.21% < 0.001 -12.15% 0.55 
 
Structural OCT 
EZ Width 
(μm) 
NA 2169 ± 1454 2341 ± 1755    7.94% 0.70 
 
MAIA 
microperimetry 
Mean 
Sensitivity 
(dB) 
NA 16.1 ± 8.2 12.1 ± 4.9    -13.57% 0.31 
P values were based on Generalized Estimating Equation (GEE, accounting for the inter-ocular subject correlation), and adjusted for multiple 
comparisons using Holm-Bonferroni method. SCP: superficial capillary plexus, DCP: deep capillary plexus, EZ: ellipsoid zone, MAIA: Macular Integrity 
Assessment microperimetry, NA: not applicable 
to healthy controls. Outer retinal degeneration and decreased macular sensitivity were 
also detected, which significantly correlated with the measured vessel density in the 
retinal OCT angiograms. Although, MYO7A patients had significantly worse VA than 
USH2A patients, no significant differences were observed in OCT, OCTA, or 
microperimetry parameters. 
RP is characterized by progressive degeneration of rod photoreceptors, which typically 
begins at the mid-periphery, sparing the cones at the centre of the fovea until late stages 
of the disease. This explains the peripheral loss of photoreceptor bands (ONL, external 
limiting membrane, and EZ) on cross-sectional OCT, with a relatively preserved island of 
retinal tissue at the center. The death of photoreceptors can also explain the decreased 
macular sensitivity measured by mircoperimetry. Vascular changes in retinal circulation 
would then be expected secondary to the decreased metabolic needs in the degenerated 
regions. Decreased perfusion was observed in the OCTA of the unsegmented retinal slab, 
as well as the superficial and deep capillary plexuses. 
Based on published experiments on oxygen metabolism in the retina, the deep and to 
lesser extent, intermediate retinal capillary plexuses were suggested to be partially 
responsible for supplying photoreceptors with oxygen.[34] Previous work has not 
suggested a linkage between the superficial plexus and photoreceptor metabolism.[35] 
Thus, we would expect the deep and intermediate capillary plexuses to be affected in 
USH, but not the superficial plexus.[28] However, the commercial OCTA machines follow 
the 2-layer segmentation scheme, which divides the retinal circulation into two plexuses; 
superficial and deep, incorporating most of the intermediate capillary plexus with the 
superficial slab. Therefore, changes were detected in both the superficial and deep 
plexuses. Additionally, the extensive thinning of the outer retina would allow higher 
oxygen diffusion to retinal layers, resulting in reflex autoregulatory constriction of retinal 
vessels and reduction in the measured vessel density. 
Quantification of CC by OCTA is inherently technically-challenging due the effect of 
shadowing, projection, and motion artifacts.[36] Therefore, CC slabs were assessed 
qualitatively for the purpose of this study. Unlike the retinal circulation, the choriocapillaris 
was different in the two USH groups with the CC in MYO7A patients affected earlier and 
more severely than the USH2A group. Choroidal blood flow has been long considered to 
be only minimally regulated by oxygen levels.[37] Thus, changes in metabolic demand 
secondary to neural retinal degeneration would not be expected to affect choroidal blood 
flow. The retinal pigment epithelium (RPE) is essential for the development and 
maintenance of the CC integrity via RPE-specific factors such as vascular endothelial 
growth factor (VEGF) and pigment epithelium-derived factor (PEDF).[38 39] The usherin 
protein, encoded by the USH2A gene, has been found to be expressed specifically in the 
inner segments of the photoreceptors but not the RPE.[15] Thus, in USH2A patients, prior 
to photoreceptor degeneration, the structure of the RPE is initially intact, maintaining the 
viability of CC layer. In contrast, the myosin VIIa protein is mainly expressed in the RPE, 
therefore, in MYO7A disease the RPE will be directly affected with subsequent earlier 
defects seen in the choriocapillaris.[16 40] The increased flow signal at the edges of lost 
CC needs to be interpreted cautiously. These regions might be corresponding to areas 
where RPE was disrupted prior to the loss of CC, leading to increased OCT signal 
reaching the CC, and consequently increased signal on the OCT angiograms, without 
actual increase in CC blood flow. 
There are contrasting reports in the literature either suggesting significant hypoperfusion 
of the CC in RP,[30 31 41 42] whilst others have found no difference between disease 
and healthy groups.[43-45] This disparity may be due to the genetically- and 
phenotypically heterogeneous patients, representing a wide-spectrum of 
pathophysiological mechanisms. Different modalities, including fluorescein angiography 
(FA),[46] color Doppler ultrasonography,[47] functional MRI,[48 49] bidirectional laser 
Doppler velocimetry,[50] laser speckle flowgraphy,[32] and confocal laser Doppler 
flowmetry have shown altered ocular blood flow in RP.[51]  
In the retinal circulation, various OCTA studies reported decreased flow signal in the 
superficial and deep plexuses,[31 42-45 52 53] with the DCP being reported to be more 
severely affected in several studies.[42 43 53] Moreover, Toto[31] and Koyanagi[52] and 
colleagues observed significant changes in the more peripheral parafoveal regions, but 
not the central foveal region, which are consistent with our findings. However, one study 
by Rezaei et al. [30] qualitatively assessed superficial and deep retinal layers and 
observed vascular defects only in the periphery of the deep plexus, but not the superficial 
layer in the severe group of RP patients. Additionally, they reported no vascular changes 
in the mildly affected subjects of their RP cohort.[30] The discrepancy in the findings can 
be attributed to the variations in the OCT machine, image processing methods, OCTA 
slab definition, as well as the differences in RP patients’ characteristics. 
This study provides valuable information on the correlation of vascular perfusion defects 
with structural and functional abnormalities, providing an insight into the residual vascular 
function within the degenerating retina. This is particularly important for understanding 
and planning therapeutic interventions for Usher syndrome. There were several 
limitations including the cross-sectional design and modest number of participants, 
especially in the MYO7A cohort, but these are rare disease cohorts. Larger studies with 
longitudinal data might be needed to confirm these results and better predict disease 
pathophysiology and progression. In addition, using OCTA is inherently associated with 
disadvantages as image quality is highly dependent on patient’s condition and 
cooperation.[54] Thus, understanding of OCTA image artifacts is essential for appropriate 
interpretation and processing of the angiograms, as well as developing advanced image 
analysis tools.[55 56] Algorithms to remove projection and motion artifacts, as well as 
machine learning and averaging techniques have shown promising results for reliable 
segmentation, visualization, and quantification of OCT angiograms.[57-59] 
In conclusion, OCTA was able to characterize microvascular changes in retinal and 
choroidal circulations in the macula of USH patients. Decreased vessel density was 
detected in the SCP and DCP of MYO7A and USH2A patients. Choriocapillaris defects 
were detected earlier and more commonly in MYO7A than USH2A patients. OCTA 
vascular alterations in the retina correlated strongly with OCT photoreceptor degeneration 
and retinal sensitivity. Our findings suggest that OCTA might provide better understanding 
of the pathophysiology of retinitis pigmentosa, as well as the associations between 
vascular abnormalities and specific gene mutations. 
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FIGURE LEGENDS 
 
FIGURE 1. Optical coherence tomography (OCT), OCT angiography (OCTA), and 
microperimetry sensitivity maps of a healthy control, USH2A and MYO7A 
patients. (A1-C1): En face OCT angiograms of the inner retina. Retinal circulation was 
further divided into superficial capillary plexus (SCP, A2-C2) and deep capillary plexus 
(DCP, A3-C3). Boundaries of the segmented slabs correspond to the green lines in the 
cross-sectional OCT image in A4. Angiograms show capillary loss in all retinal slabs in 
USH2A (B1-B3) and MYO7A (C1-C3) patients compared to the healthy participant (A1-
A3). Microvascular changes were more pronounced in the DCP, and in the peripheral 
parts of the angiograms, corresponding to areas of outer retinal degeneration on OCT 
(B4,C4), and areas of decreased macular sensitivity on microperimetry sensitivity maps 
(B5,C5). Clinical data including age, gender, visual acuity (VA) and/or MAIA 
microperimetry mean sensitivity are provided on A4-C4 panels. 
 
FIGURE 2. Vessel density measurements and their relationship with macular 
structure and function. (A): box and whisker plots demonstrating the differences in 
OCT angiography vessel density of the inner retinal slab, as well as the superficial 
capillary plexus (SCP) and deep capillary plexus (DCP) between healthy participants, 
USH2A and MYO7A patients. Significant reductions in vessel density was found in all 
plexuses between patients and healthy participants. However, no significant differences 
were observed between USH2A and MYO7A groups. (B and C): scatter plots illustrating 
the positive correlation between macular perfusion at the level of the DCP, and macular 
sensitivity and the width of ellipsoid zone (EZ), respectively. 
 
FIGURE 3. Optical coherence tomography angiography (OCTA) of the 
choriocapillaris (CC) in a healthy control, as well as USH2A and MYO7A patients 
at different age groups. OCT angiograms of USH2A patients (B1-B3) were 
comparable to control angiograms (A1-A3). Similarly, no significant changes can be 
detected in CC of young MYO7A (C1). However, peripheral CC loss was observed in 
the angiograms of MYO7A patients at the fourth decade of life or later (white arrows, C2 
and C3). Areas of higher flow signal were also detected at the edges of the relatively 
preserved central CC island (yellow arrow heads, C2 and C3). Visual acuity (VA) and 
MAIA microperimetry mean sensitivity of the patients are added at the right bottom 
corners of the angiograms (B1-B3 and C1-C3). 
 
